18:20 EST Ascendis Pharma (ASND) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASND:
- Ascendis Pharma announces FDA approval of Yuviwel
- Ascendis Pharma trading halted, news pending
- Ascendis Pharma Sets March 23 AGM to Approve 2025 Results, Board Changes and Buyback Mandate
- Ascendis Pharma Earnings Call Highlights Growth Momentum
- Ascendis Pharma price target raised to $273 from $240 at Wedbush